Javascript must be enabled to continue!
Interaction between veno-arterial extracorporeal membrane oxygenation and the right ventricle
View through CrossRef
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): Fundación Alfonso Martín Escudero
The response of the right ventricle (RV) to the hemodynamic effects of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is unpredictable. We hypothesized if presence of uni- or bi-ventricular failure before implantation and cannulation strategy may influence. We assessed RV performance during VA-ECMO support and identify RV-related predictors of weaning. Methods. Changes of RV size and function during VA-ECMO by echocardiography were retrospectively analyzed in 87 patients. Predictors of weaning were evaluated by logistic regression. Results. RV echocardiographic parameters did not vary significantly during VA-ECMO, neither after stratification by cannulation type or presence of isolated or biventriular failure. Succesful weaning was conditioned by absence of RV dysfunction before implantation (OR 14.7,95%CI 13.3-140.3;p = 0.025) or in the last day of support (OR 9.5; 95%CI 1.6-54;p = 0.011) and was favored by a total or partial recovery of RV function during the assistance (OR 6.2; 95%CI 1.7-22.4;p = 0.005). RV improvement was more often observed in patients with acute RV failure, while VA-ECMO configuration had no effect. Conclusions. Preservation or improvement of RV function during VA-ECMO support is essential for weaning. RV echocardiographic performance does not change significantly during VA-ECMO and is not influenced by cannulation type or presence of uni- or bi-ventricular failure before implantation. Echo parameters evolution during VA-ECMOPre-ECMO< 24h on ECMO> 24h on ECMOpNn = 68n = 68n = 63LV diastolic diameter, mm (mean ± SD)53.34 ± 15.5954.86 ± 13.8956.18 ± 14.620.317LV systolic diameter, mm45.28 ± 11.6745.17 ± 14.5846.07 ± 15.590.963LVEF, n (%)20 (10-38.75)17.5 (10-30)25 (10-40)0.102RV basal diameter, mm (mean ± SD)41.05 ± 9.7938.92± 9.1740.05 ± 9.560.484RV systolic disfunction, n (%)65 (95.6)65 (95.5)43 (68.2)0.073Tricuspid regurgitation, n (%)50 (73.4)37 (54.3)49 (77.8)0.146Pulmonary systolic pressure, mmHg (mean ± SD)41.54 ± 24.1339.09 ± 20.2445.29 ± 25.730.783Aortic regurgitation, n (%)47 (69.1)39 (57.4)35 (55.5)0.775Mitral regurgitation, n (%)64 (94.1)48 (70.5)44 (69.8)0.591Dd diastolic diameter; EF: ejection fraction; LV: left ventricle; LVOT: left ventricle outflow tract; RV: right ventricle; RVOT: right ventricle outflow tract; VTI: velocity time integralAbstract Figure. Right ventricular function predictors
Title: Interaction between veno-arterial extracorporeal membrane oxygenation and the right ventricle
Description:
Abstract
Funding Acknowledgements
Type of funding sources: Private company.
Main funding source(s): Fundación Alfonso Martín Escudero
The response of the right ventricle (RV) to the hemodynamic effects of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is unpredictable.
We hypothesized if presence of uni- or bi-ventricular failure before implantation and cannulation strategy may influence.
We assessed RV performance during VA-ECMO support and identify RV-related predictors of weaning.
Methods.
Changes of RV size and function during VA-ECMO by echocardiography were retrospectively analyzed in 87 patients.
Predictors of weaning were evaluated by logistic regression.
Results.
RV echocardiographic parameters did not vary significantly during VA-ECMO, neither after stratification by cannulation type or presence of isolated or biventriular failure.
Succesful weaning was conditioned by absence of RV dysfunction before implantation (OR 14.
7,95%CI 13.
3-140.
3;p = 0.
025) or in the last day of support (OR 9.
5; 95%CI 1.
6-54;p = 0.
011) and was favored by a total or partial recovery of RV function during the assistance (OR 6.
2; 95%CI 1.
7-22.
4;p = 0.
005).
RV improvement was more often observed in patients with acute RV failure, while VA-ECMO configuration had no effect.
Conclusions.
Preservation or improvement of RV function during VA-ECMO support is essential for weaning.
RV echocardiographic performance does not change significantly during VA-ECMO and is not influenced by cannulation type or presence of uni- or bi-ventricular failure before implantation.
Echo parameters evolution during VA-ECMOPre-ECMO< 24h on ECMO> 24h on ECMOpNn = 68n = 68n = 63LV diastolic diameter, mm (mean ± SD)53.
34 ± 15.
5954.
86 ± 13.
8956.
18 ± 14.
620.
317LV systolic diameter, mm45.
28 ± 11.
6745.
17 ± 14.
5846.
07 ± 15.
590.
963LVEF, n (%)20 (10-38.
75)17.
5 (10-30)25 (10-40)0.
102RV basal diameter, mm (mean ± SD)41.
05 ± 9.
7938.
92± 9.
1740.
05 ± 9.
560.
484RV systolic disfunction, n (%)65 (95.
6)65 (95.
5)43 (68.
2)0.
073Tricuspid regurgitation, n (%)50 (73.
4)37 (54.
3)49 (77.
8)0.
146Pulmonary systolic pressure, mmHg (mean ± SD)41.
54 ± 24.
1339.
09 ± 20.
2445.
29 ± 25.
730.
783Aortic regurgitation, n (%)47 (69.
1)39 (57.
4)35 (55.
5)0.
775Mitral regurgitation, n (%)64 (94.
1)48 (70.
5)44 (69.
8)0.
591Dd diastolic diameter; EF: ejection fraction; LV: left ventricle; LVOT: left ventricle outflow tract; RV: right ventricle; RVOT: right ventricle outflow tract; VTI: velocity time integralAbstract Figure.
Right ventricular function predictors.
Related Results
Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality
Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality
Background: Extracorporeal membrane oxygenation is a cardiopulmonary supportive therapy. In this study, we reviewed our experience with extracorporeal membrane oxygenation support ...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
Impact of Cannulation Strategy and Extracorporeal Blood Flow on Recirculation During Veno‐Venous Extracorporeal Membrane Oxygenation
Impact of Cannulation Strategy and Extracorporeal Blood Flow on Recirculation During Veno‐Venous Extracorporeal Membrane Oxygenation
ABSTRACTIntroductionVeno‐venous extracorporeal membrane oxygenation (V‐V ECMO) is increasingly used in the treatment of severe respiratory failure. Despite a significant increase i...
Extracorporeal Oxygenation (ECMO) in Patients with Acute Respiratory Failure
Extracorporeal Oxygenation (ECMO) in Patients with Acute Respiratory Failure
Abstract: Extracorporeal membrane oxygenation (ECMO) is a method for oxygenation and removal of carbon dioxide in patients with respiratory failure in whom we cannot achieve that ...
Endoscopic anatomy of the ventricles
Endoscopic anatomy of the ventricles
The cerebral ventricles are structures known since antiquity. At the beginning of its description there was a belief that human thoughts and intellect were generated inside the ven...
Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation
Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation
AbstractBackgroundCalcium channel blockers and angiotensin II receptor blockers are commonly prescribed to treat hypertension. Massive overdoses can cause both distributive and car...
Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock
Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock
There are contrasting data on concomitant Impella device in cardiogenic shock patients treated with venoarterial extracorporeal membrane oxygenation (VA ECMO) (ECPELLA). This study...
“Decompression illness” on extracorporeal membrane oxygenation
“Decompression illness” on extracorporeal membrane oxygenation
Abstract
Background
Extracorporeal membrane oxygenation (ECMO) is increasingly being used for critically ill patients with cardiopulmonary failure. Air in the ECMO circuit...

